Dosimetric Evaluation of Two Multileaf Collimator Systems in Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Stage IIIC Cervical Cancer with Lymph Node Metastases - Quiz - MDSpire

Dosimetric Evaluation of Two Multileaf Collimator Systems in Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Stage IIIC Cervical Cancer with Lymph Node Metastases

  • By

  • Hui Xiao

  • Ang Qu

  • Haitao Sun

  • Xile Zhang

  • Nan Zhang

  • Shuhua Wei

  • Xiuwen Deng

  • Chunxiao Li

  • Junjie Wang

  • Ping Jiang

  • April 23, 2026

  • 0 min

Share

Original Source(s)

Dosimetric Evaluation of Two Multileaf Collimator Systems in Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Stage IIIC Cervical Cancer with Lymph Node Metastases

  • by Hui Xiao, Ang Qu, Haitao Sun, Xile Zhang, Nan Zhang, Shuhua Wei, Xiuwen Deng, Chunxiao Li, Junjie Wang, Ping Jiang

  • April 23, 2026

Related Content

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer